CityMD Agrees to $12 Million to Pay Department of Justice Over Alleged Covid-19 Payments Violation
By Sabela Ojea
CityMD has agreed to pay more than $12 million to the Department of Justice for allegedly submitting false claims for payment for Covid-19 testing to the Health Resources and Services Administration governmental program for uninsured patients.
The urgent-care chain's settlement resolves allegations related to the violation of the False Claims Act, the Department of Justice's Office of Public Affairs said Friday. The act encourages people with knowledge of suspected false claims to sue on the government's behalf.
CityMD is owned by Walgreens Boots Alliance after the pharmacy operator acquired Summit Health in a transaction worth roughly $9 billion including debt late in 2022.
Walgreens didn't immediately respond to a request for comment.
From Feb. 4, 2020, to April 5, 2022, CityMD allegedly knowingly submitted payment for Covid-19 testing to the Uninsured Program for individuals who had health insurance coverage when CityMD administered those tests, the DOJ said.
CityMD cooperated with the investigation and voluntarily contracted a third party to assist in determining the amount of the losses the U.S. contends were caused by claims submitted to the Uninsured Program for patients who had health insurance, the DOJ said.
Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix
(END) Dow Jones Newswires
June 07, 2024 17:06 ET (21:06 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What Does Chipotle’s Stock Split Mean for Investors?
-
5 Stocks to Buy Before the Fed Cuts Interest Rates in 2024
-
Markets Brief: Inflation Is Back In the Spotlight
-
What’s Happening In the Markets This Week
-
What a Strong Economy Now Means for the Rest of 2024
-
4 Wide-Moat Stocks to Buy for the Long Term While They’re Undervalued Today
-
Markets Brief: Four Stocks Made Up 80% of the Gains. Can It Last?
-
Is It Time to Ditch Your Money Market Fund for Longer-Term Bonds?
-
Investment Opportunities in US Renewable Energy
-
10 Best Value Stocks to Buy for the Long Term
-
A Wide-Moat Stock to Invest in That’s 35% Undervalued
-
Airbus: We Believe Investors May Be Overreacting to Lowered Guidance and Charge
-
10 Stocks the Best Fund Managers Have Been Selling
-
TSMC Fair Value Raised 45% on Stronger AI Demand
-
3 International Stocks the Best Managers Have Been Buying
-
After Earnings, Is Adobe Stock a Buy, a Sell, or Fairly Valued?